In today's episode, Ellie Wolmark is joined by Professor George Vassiliou to talk about his research on clonal haematopoiesis and a new clinic that he has recently set up. We'll uncover what clonal haematopoiesis is and how it can sometimes lead to the development of blood cancer.

George is a CRUK Senior Clinical Fellow and Professor of Haematological Medicine at the University of Cambridge, UK. He is also a member of Faculty at the Wellcome-MRC Cambridge Stem Cell Institute and a Consultant Haematologist at Cambridge University Hospitals NHS Foundation Trust.

Integrated Cancer Medicine: Research in Focus

Clonal haematopoiesis and using it to try to predict whether cancer will develop

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

New tracks tagged #Early Prediction